Reply to F.-C. Bidard et al

J Clin Oncol. 2015 May 10;33(14):1623. doi: 10.1200/JCO.2014.60.5519. Epub 2015 Apr 13.

Authors

Jeffrey B Smerage¹, William E Barlow², Gabriel N Hortobagyi³, Daniel F Hayes⁴

Affiliations

¹ University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.
² SWOG Statistical Center, Seattle, WA.
³ University of Texas MD Anderson Cancer Center, Houston, TX.
⁴ University of Michigan Comprehensive Cancer Center, Ann Arbor, MI hayesdf@umich.edu.

PMID: 25870090
DOI: 10.1200/JCO.2014.60.5519

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Agents / therapeutic use*
Breast Neoplasms / drug therapy*
Drug Substitution*
Female
Humans
Neoplastic Cells, Circulating / pathology*

Substances

Antineoplastic Agents